As the race heats up among enterprise AI software providers, C3.ai, is emerging as a key player with its stock skyrocketing over +20% in today’s trading frenzy. Fueled by the buzz surrounding the company’s impressive quarterly results, C3.ai’s software ecosystem facilitates large-scale AI, predictive analytics, and IoT applications. Notably, its closest rival, BlackLine (BL), is trailing far behind with an -8% downturn.
Image Source: Zacks Investment Research
Revving up: Revenue & Contract Growth Ignites C3.ai’s Post-Earnings Rally
In its pursuit of substantial profitability since its 2020 IPO, C3.ai witnessed a robust 18% surge in total sales during its fiscal third quarter, hitting $78.4 million. Surpassing Zacks’ estimates by 3%, the company’s revelation of an 80% year-over-year spike in customer engagement sent waves of excitement through the investor community. C3.ai finalized 50 agreements, more than doubling from the previous year, including partnerships with industry heavyweights such as Boston Scientific (BSX), T-Mobile (TMUS), AbbVie (ABBV), and the revered U.S. Department of Defense.
Image Source: Zacks Investment Research
Additionally, C3.ai’s Non-GAAP gross profit of $54.7 million, sporting a 70% gross margin, was a reassuring pillar. Despite reporting a net loss of -$72.63 million and -$0.13 per share, the company managed to surpass expectations, with the net loss significantly narrower compared to the same quarter last year. Impressively, C3.ai has now exceeded its bottom line projections for 12 consecutive quarters.
Image Source: Zacks Investment Research
The Allure of C3.ai’s Suite
C3.ai’s strong bookings underline its dominance in Enterprise AI, capitalizing on the surging market interest and demand for AI solutions. Positioned as the leading provider of AI-powered predictive maintenance solutions, C3.ai’s suite boasts five essential software components: C3 AI Application Platform, C3 AI Applications, C3 AI EX Machina (No-Code AI), C3 AI CRM, and C3 AI Data Vision.
This comprehensive suite is attracting a diverse array of enterprises across various sectors, as depicted in C3.ai’s third-quarter bookings distribution chart below. Noteworthy is C3 AI EX Machina, which empowers developers to harness AI insights at scale without the need for coding.
Image Source: C3.ai Earnings Release
Promising Projections: Favorable Revenue Forecast
Looking ahead to its fiscal fourth quarter, C3.ai anticipates revenue in the range of $82-$86 million, aligning closely with the Zacks Consensus estimate of $84.08 million, reflecting a 16% growth. The full-year fiscal 2024 sales forecast sits at around $306-$310 million, with Zacks’ estimates hovering at $305.58 million, indicating a 14% upsurge.
Image Source: Zacks Investment Research
Final Thoughts
Establishing itself as a frontrunner among AI companies, C3.ai currently holds a Zacks Rank #3 (Hold). The trajectory of its stock and potential profitability hinges significantly on forthcoming earnings estimate revisions. With an enviable top-line growth trajectory, C3.ai continues to be a compelling investment prospect in the ever-evolving AI landscape.
Seeking Intelligent Investments?
Zacks Senior Stock Strategist, Kevin Cook, reveals 5 hand-picked stocks poised for explosive growth in the Artificial Intelligence domain. By 2030, the AI industry is slated to yield an economic impact comparable to the inception of the internet and iPhone, a staggering $15.7 Trillion prediction.
Today, dive into the future wave, automation that questions, adapts, and fuels innovation. As one company in this select group articulates, “Automation liberates individuals from the tedious to accomplish the extraordinary.”
Download Free ChatGPT Stock Report Right Now >>
C3.ai, Inc. (AI) : Free Stock Analysis Report
Boston Scientific Corporation (BSX) : Free Stock Analysis Report
AbbVie Inc. (ABBV) : Free Stock Analysis Report
T-Mobile US, Inc. (TMUS) : Free Stock Analysis Report
BlackLine (BL) : Free Stock Analysis Report
For the original article from Zacks.com, click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
